CAXTON ASSOCIATES LP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2020$701,000
-31.3%
6,860
-27.4%
0.06%
-67.4%
Q1 2020$1,020,000
+131.8%
9,447
+149.8%
0.19%
+211.7%
Q4 2019$440,0003,7820.06%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders